Keep Muscle · Answer guide
How to prevent muscle loss on GLP-1 medicines
Adequate nutrition and progressive resistance exercise are the main supports for preserving muscle during weight loss. Protein matters, but protein alone does not replace strength training. A fall in measured lean mass is not automatically the same amount of lost skeletal muscle, so strength and function deserve attention too.
Evidence behind this answer
Sources checked November 1, 2026: [1] Four-society advisory: nutritional priorities during GLP-1 therapy, 2025[2] ADA: pharmacologic obesity treatment, nutrition and muscle assessment[3] NIH: nutrition and exercise supplements
Evidence in context
Preserving muscle takes more than adding a shake.
What the source reports
The advisory pairs adequate nutrition with structured strength training during GLP-1 treatment. It notes that increasing protein alone is unlikely to preserve muscle adequately without a resistance-training stimulus.
How far the conclusion goes
An advisory synthesizes evidence and clinical priorities. It is not a trial proving that one protein product or one exercise routine prevents muscle loss in everyone.
If weight is falling, what else deserves attention?
Food intake, tolerance of treatment, strength and physical capacity belong in follow-up. A plan should fit current ability and health limitations rather than assume that a lower scale reading captures every outcome.
Source: Four-society advisory: nutritional priorities during GLP-1 therapy, 2025 ↗
Checked November 1, 2026. Our interpretation is educational; this is not an independent clinical review.
Why weight loss can include more than fat
A smaller number on the scale can include changes in fat, water and other lean tissue. DXA “lean mass” includes more than skeletal muscle, and consumer scales estimate composition indirectly. The practical concern is whether the weight-loss plan supports health and everyday capability. Someone who is becoming weaker, eating very little or struggling with normal activities needs more than reassurance that the scale is moving.
Build resistance exercise into the plan
The 2025 four-society nutrition advisory emphasizes structured resistance training alongside adequate protein during GLP-1 treatment. Training can involve machines, free weights, bands or appropriately chosen body-weight movements. The load and progression should fit ability, injury history and medical circumstances. A beginner does not need an athlete’s program. A qualified professional can help make the plan manageable and progressively challenging rather than exhausting.
Do not let reduced appetite become inadequate nutrition
Appetite reduction can make it harder to meet protein, fluid and other nutritional needs. Include protein-containing foods within meals you tolerate, rather than assuming a supplement will fix a very limited diet. Persistent nausea, vomiting or difficulty eating deserves discussion with the prescriber. Medication adjustment and nutrition support may be relevant. Do not change the prescribed dose solely to chase faster weight loss.
Follow strength, not only body composition
Track useful everyday outcomes such as getting out of a chair, carrying groceries or completing the resistance exercises you have been taught. These are observations, not a self-diagnostic test. Bring substantial decline, falls or persistent weakness to the care team. A dietitian or exercise professional may help identify an intake or training problem before it becomes entrenched. The goal is a sustainable treatment response with preserved capability.
Related questions
Does everyone taking a GLP-1 lose dangerous amounts of muscle?
No. Individual outcomes differ, and a trial average for lean mass is not an individual diagnosis. Baseline health, intake, activity and the measurement method matter.
Can collagen replace resistance training?
No. A protein product does not reproduce the muscle-loading stimulus of resistance exercise.
Sources
General information, not an individual diagnosis or treatment plan. Product-specific approval, risks and eligibility must be checked against the current label and clinical assessment. How we publish · Report a correction